Related Experiment Video
Updated: Jun 7, 2026
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
Published on: May 16, 2012
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
Salomé González-Reyes1, Jesús M Fernández, Luis O González
1Unidad de Investigación, Hospital de Jove, Gijón, Spain. investigacion@hospitaldejove.com
Background:
Toll-like receptors (TLRs) have garnered an extraordinary amount of interest in cancer research due to their role in tumor progression. By activating the production of several biological factors, TLRs induce type I interferons and other cytokines, which drive an inflammatory response and activate the adaptive immune system. The aim of this study was to investigate the expression and clinical relevance of TLR3, 4, and 9 in prostate cancer.
Methods:
The expression levels of TLR3, TLR4, and TLR9 were analyzed on tumors from 133 patients with prostate cancer. The analyses were performed by immunohistochemistry on tissue arrays and real time-PCR.
Results:
Cancerous cells showed high expression levels of TLRs compared with controls. Samples of carcinomas with recurrence exhibited a significant increase in the mRNA levels of TLR3, TLR4, and TLR9. In addition, the tumors that showed high TLR3 or TLR9 expression levels were significantly associated with higher probability of biochemical recurrence.
Conclusion:
TLR expression is associated with prostate cancer with recurrence and the role of TLR receptors in the biology of malignancy merits study. Therapeutic strategies to boost or block TLRs may be of interest.
Insights
Toll-like receptors (TLRs) are highly expressed in prostate cancer cells, particularly in recurrent cases. High TLR3 or TLR9 expression indicates a greater chance of biochemical recurrence in prostate cancer patients.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Toll-like receptors (TLRs) play a crucial role in cancer progression by modulating immune responses.
- TLRs activate cytokine production, leading to inflammation and adaptive immunity activation.
Purpose of the Study:
- To investigate the expression and clinical significance of Toll-like receptors 3, 4, and 9 in prostate cancer.
- To determine the association between TLR expression and prostate cancer recurrence.
Main Methods:
- Immunohistochemistry on tissue arrays and real-time PCR were used to analyze TLR3, TLR4, and TLR9 expression.
- Tumor samples from 133 prostate cancer patients were analyzed.
Main Results:
- Prostate cancer cells exhibited elevated TLR expression compared to controls.
- Increased mRNA levels of TLR3, TLR4, and TLR9 were observed in recurrent carcinomas.
- High TLR3 or TLR9 expression correlated significantly with an increased likelihood of biochemical recurrence.
Conclusions:
- TLR expression is linked to prostate cancer recurrence.
- Further research into the role of TLRs in cancer biology is warranted.
- Targeting TLRs therapeutically may offer new treatment strategies for prostate cancer.
